Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study

Background: Anti-cytosolic 5′-nucleotidase 1A (anti-cN1A) antibodies were proposed as a biomarker for the diagnosis of inclusion body myositis (IBM), but conflicting specificity and sensitivity evidence limits its use. Our study aimed to assess the diagnostic accuracy of anti-cN1A in a cohort of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Porcelli, Brunetta, d’Alessandro, Miriana, Gupta, Latika, Grazzini, Silvia, Volpi, Nila, Bacarelli, Maria Romana, Ginanneschi, Federica, Biasi, Giovanni, Bellisai, Francesca, Fabbroni, Marta, Bennett, David, Fabiani, Claudia, Cantarini, Luca, Bargagli, Elena, Frediani, Bruno, Conticini, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377506/
https://www.ncbi.nlm.nih.gov/pubmed/37509600
http://dx.doi.org/10.3390/biomedicines11071963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377506/
https://www.ncbi.nlm.nih.gov/pubmed/37509600
http://dx.doi.org/10.3390/biomedicines11071963

Ejemplares similares